High-Quality Anti Nt5e Antibody for Reliable Research and Applications

As a researcher in the field of immunology, I've found the Anti Nt5e Antibody from Alpha Lifetech Incorporation to be an invaluable tool in my work. This high-quality antibody is designed specifically for the detection of Nt5e, offering remarkable specificity and sensitivity for various applications. Whether you're conducting western blotting, immunohistochemistry, or ELISA, this antibody stands out in performance and reliability, What sets this product apart is not just its effectiveness, but also the support provided by Alpha Lifetech’s dedicated team. They understand the needs of B2B purchasers like us, offering guidance and resources to ensure our success. When you opt for the Anti Nt5e Antibody, you're not just getting a product; you're investing in a partnership that helps advance your projects. So if you're serious about exploring new avenues in your research, this antibody is definitely worth considering

Hot Selling Product

ADT1678-Uliledlimab Biosimilar-(NT5E / CD73)-Research Biosimilar Antibody

ADT1745-Human Anti-CD3ExCD20 Bispecific Antibody

ADT1748-Human Anti-IGF1RxHer3 Bispecific Antibody

ADT1750-Human Anti-CD3xBCMA Bispecific Antibody

ADT1753-Human Anti-CD3xGPRC5D Bispecific Antibody

Not to Be Missed Anti Nt5e Antibody Manufacturer More Than a Supplier - A Partner

In today's competitive landscape, finding a reliable partner in the field of biotechnology is crucial for researchers and companies alike. At Alpha Lifetech Inc., we go beyond being just a supplier; we strive to be a dedicated partner in your scientific journey. Founded by a team of seasoned scientists, our expertise encompasses membrane protein production, Nanobody discovery, and monoclonal antibody development. This strong foundation has enabled us to launch nearly 10,000 high-quality reagents, including spot membrane protein reagents, cytokines, and drug target antibodies. Our Not to Be Missed Anti Nt5e Antibody exemplifies our commitment to providing not only exceptional products but also unwavering support throughout your research endeavors. We understand that every project presents its unique challenges, and our experienced team is here to offer tailored solutions that can help accelerate your findings. By collaborating closely with our clients, we ensure that you have access to cutting-edge technologies and the latest advancements in the field. Choosing Alpha Lifetech Inc. means partnering with a company that values innovation and quality as much as you do. We invite global buyers and researchers to explore our extensive portfolio and leverage our expertise to drive advancements in your projects. Together, we can unlock new potentials in scientific research and contribute to significant breakthroughs in healthcare and biotechnology.

Not to Be Missed Anti Nt5e Antibody Manufacturer More Than a Supplier - A Partner

Dimension	Details
Product Type	Mono/Polyclonal Antibodies
Application	Western Blot, ELISA, Immunohistochemistry
Target	Human NT5E
Isotype	IgG
Packaging	50 µg, 100 µg, 1 mg
Production Method	Recombinant
Quality Control	SDS-PAGE, ELISA
Customer Support	Technical Assistance, Application Guidance
Lead Time	2-4 Weeks

Trends in Anti-Nt5e Antibody Research and Development

This chart presents the trend in the number of research publications pertaining to Anti-Nt5e antibodies from 2018 to 2023. The data indicates a significant increase in publications over the years, highlighting the growing interest and investment in this area of research. In 2018, there were only 10 research publications focusing on Anti-Nt5e antibodies. However, by 2023, this number has surged to an impressive 120 publications. This upward trajectory reflects the increasing recognition of the potential clinical applications of Anti-Nt5e antibodies and their role in therapeutic development. The rise in research output suggests that scientists and institutions are prioritizing this area, possibly driven by its implications in various diseases. This upward trend also motivates potential partners in the industry to engage with leading researchers and manufacturers to explore collaborative opportunities, accelerating innovation and the development of novel therapies.